Historical record - last NADAC effective date: 2/22/2023
Product Information
OLMESARTAN MEDOXOMIL 40 MG TAB is a generic product labeled by Lifestar Pharma LLC, priced at $0.1286 per EA under NDC 70756081030. Its NADAC has been published 133 times since Aug 12, 2020.
FDA first approved this application on Jul 18, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the OLMESARTAN MEDOXOMIL market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Lifestar Pharma LLCNDC
70756081030
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/22/2023
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207135FDA Approved
7/18/2019
TE Code
AB
On Market Since
5/1/2020
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN MEDOXOMIL 40 MG TAB has been published 133 times since Aug 12, 2020, and over the history we have for it it has declined 33.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1286 per EA |
|---|---|
| All-time high | $0.1929 (Aug 12, 2020) |
| All-time low | $0.1286 (Feb 22, 2023) |
| Median price | $0.1557 |
| Average price | $0.1556 |
| Largest weekly change | -23.1% (Sep 23, 2020) |
| Weeks tracked | 133 |
| Tracking since | Aug 12, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-21.3%
All
-33.3%
Last surveyed Feb 22, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lifestar Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
OLMESARTAN MEDOXOMIL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLMESARTAN MEDOXOMIL 40 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 40 MG TAB, manufactured by Lifestar Pharma LLC, is $0.1286 per EA (NDC 70756081030), effective Feb 22, 2023.
How has the price of OLMESARTAN MEDOXOMIL 40 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 40 MG TAB has declined 33.3%. It has been tracked across 133 weekly CMS publications since Aug 12, 2020.
What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 40 MG TAB?
Since Aug 12, 2020, the NADAC for OLMESARTAN MEDOXOMIL 40 MG TAB has ranged from a low of $0.1286 (Feb 22, 2023) to a high of $0.1929 (Aug 12, 2020), with a median of $0.1557 per EA.
Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 40 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLMESARTAN MEDOXOMIL 40 MG TAB, is $0.1110 per EA — about 14% below OLMESARTAN MEDOXOMIL 40 MG TAB.
Who manufactures OLMESARTAN MEDOXOMIL 40 MG TAB?
OLMESARTAN MEDOXOMIL 40 MG TAB (NDC 70756081030) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.